P
Phyllis J. Goodman
Researcher at Fred Hutchinson Cancer Research Center
Publications - 190
Citations - 20622
Phyllis J. Goodman is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Prostate cancer & Prostate Cancer Prevention Trial. The author has an hindex of 48, co-authored 180 publications receiving 18637 citations.
Papers
More filters
Journal ArticleDOI
The Influence of Finasteride on the Development of Prostate Cancer
Ian M. Thompson,Phyllis J. Goodman,Catherine M. Tangen,M. Scott Lucia,Gary J. Miller,Leslie G. Ford,Michael M. Lieber,R. Duane Cespedes,JN Atkins,Scott M. Lippman,Susie M. Carlin,Anne Ryan,Connie M. Szczepanek,John Crowley,Charles A. Coltman +14 more
TL;DR: Finasteride prevents or delays the appearance of prostate cancer, but this possible benefit and a reduced risk of urinary problems must be weighed against sexual side effects and the increased risk of high-grade prostate cancer.
Journal ArticleDOI
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
Ian M. Thompson,Donna K. Pauler,Phyllis J. Goodman,Catherine M. Tangen,M. Scott Lucia,Howard L. Parnes,Lori M. Minasian,Leslie G. Ford,Scott M. Lippman,E. David Crawford,John Crowley,Charles A. Coltman +11 more
TL;DR: Biopsy-detected prostate cancer, including high-grade cancers, is not rare among men with PSA levels of 4.0 ng per milliliter or less--levels generally thought to be in the normal range.
Journal ArticleDOI
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Charles G. Moertel,Fleming Tr,Macdonald Js,Daniel G. Haller,John A. Laurie,Phyllis J. Goodman,James S. Ungerleider,W A Emerson,Douglass C. Tormey,John H. Glick +9 more
TL;DR: Adjuvant therapy with levamisole and fluorouracil should be standard treatment for Stage C colon carcinoma, and this approach should be readily adaptable to conventional medical practice.
Journal ArticleDOI
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Scott M. Lippman,Eric A. Klein,Eric A. Klein,Phyllis J. Goodman,M. Scott Lucia,Ian M. Thompson,Leslie G. Ford,Howard L. Parnes,Lori M. Minasian,J. Michael Gaziano,Jo Ann Hartline,J. Kellogg Parsons,James D. Bearden,E. David Crawford,Gary E. Goodman,Jaime Claudio,Eric Winquist,Elise D. Cook,Daniel D. Karp,Philip J. Walther,Michael M. Lieber,Alan R. Kristal,Amy K. Darke,Kathryn B. Arnold,Patricia A. Ganz,Regina M. Santella,Demetrius Albanes,Philip R. Taylor,Jeffrey L. Probstfield,T. J. Jagpal,John Crowley,Frank L. Meyskens,Laurence H. Baker,Charles A. Coltman +33 more
TL;DR: Selenium or vitamin E, alone or in combination at the doses and formulations used, did not prevent prostate cancer in this population of relatively healthy men.
Journal ArticleDOI
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Ian M. Thompson,Donna P. Ankerst,Chen Chi,Phyllis J. Goodman,Catherine M. Tangen,M. Scott Lucia,Ziding Feng,Howard L. Parnes,Charles A. Coltman +8 more
TL;DR: Higher PSA level, abnormal DRE result, older age at biopsy, and African American race were predictive for high-grade disease, whereas a previous negative prostate biopsy was associated with reduced risk.